To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
USA116th CongressHR-5587| House
| Updated: 1/23/2020
Collin C. Peterson
Democratic Representative
Minnesota
Cosponsors (13)
Mark Pocan (Democratic)Thomas Massie (Republican)Denver Riggleman (Republican)Glenn Grothman (Republican)Anthony Brindisi (Democratic)James Comer (Republican)Salud O. Carbajal (Democratic)Cynthia Axne (Democratic)Ron Kind (Democratic)Earl Blumenauer (Democratic)Matt Gaetz (Republican)TJ Cox (Democratic)Chellie Pingree (Democratic)
Agriculture Committee, Energy and Commerce Committee, Conservation, Research, and Biotechnology Subcommittee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD. The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Health
Administrative law and regulatory proceduresCongressional oversightDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesFood supply, safety, and labelingGovernment studies and investigationsState and local government operations
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
USA116th CongressHR-5587| House
| Updated: 1/23/2020
This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD. The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Collin C. Peterson
Democratic Representative
Minnesota
Cosponsors (13)
Mark Pocan (Democratic)Thomas Massie (Republican)Denver Riggleman (Republican)Glenn Grothman (Republican)Anthony Brindisi (Democratic)James Comer (Republican)Salud O. Carbajal (Democratic)Cynthia Axne (Democratic)Ron Kind (Democratic)Earl Blumenauer (Democratic)Matt Gaetz (Republican)TJ Cox (Democratic)Chellie Pingree (Democratic)
Agriculture Committee, Energy and Commerce Committee, Conservation, Research, and Biotechnology Subcommittee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresCongressional oversightDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesFood supply, safety, and labelingGovernment studies and investigationsState and local government operations